Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine
- PMID: 14575801
- DOI: 10.1016/j.ejphar.2003.08.083
Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine
Abstract
The action of the bradycardiac agents, cilobradine (DK-AH269) and zatebradine (UL-FS49), on the cardiac pacemaker current (If) was investigated on short Purkinje fibres from sheep hearts, using the two-microelectrode voltage-clamp technique, and on isolated rabbit sino-atrial cells with the patch clamp technique. These drugs reduce dose dependently the amplitude of the If, without modifying either the voltage dependence or the kinetics of channel activation. When voltage-clamp pulse trains were applied, cilobradine induced a use-dependent blockade of If that was stronger and faster than that with zatebradine. Recovery from blockade during prolonged hyperpolarization was significantly faster with zatebradine. Presumably, both drugs block the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel by gaining access to a binding site within the open channel pore, and are removed from the blocking site by strong hyperpolarization with large inward If through the open channel. Cilobradine, compared to zatebradine blocks If more effectively and faster in both preparations. Consequently cilobradine strongly reduces the pacemaker diastolic depolarization rate and the cell's firing frequency.
Similar articles
-
Blockade of the pacemaker current by intracellular application of UL-FS 49 and UL-AH 99 in sheep cardiac Purkinje fibers.Eur J Pharmacol. 1992 Dec 8;229(1):55-62. doi: 10.1016/0014-2999(92)90285-c. Eur J Pharmacol. 1992. PMID: 1473563
-
Bradycardic and proarrhythmic properties of sinus node inhibitors.Mol Pharmacol. 2006 Apr;69(4):1328-37. doi: 10.1124/mol.105.020701. Epub 2005 Dec 30. Mol Pharmacol. 2006. PMID: 16387796
-
Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49.Br J Pharmacol. 1994 May;112(1):37-42. doi: 10.1111/j.1476-5381.1994.tb13025.x. Br J Pharmacol. 1994. PMID: 8032660 Free PMC article.
-
Molecular regulation and pharmacology of pacemaker channels.Curr Pharm Des. 2007;13(23):2338-49. doi: 10.2174/138161207781368729. Curr Pharm Des. 2007. PMID: 17692005 Review.
-
[Selection and pharmacological characterisation of Procoralan, a selective inhibitor of the pacemaker If current].Therapie. 2004 Sep-Oct;59(5):495-505. doi: 10.2515/therapie:2004086. Therapie. 2004. PMID: 15648301 Review. French.
Cited by
-
Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.Br J Pharmacol. 2007 Jan;150(1):37-46. doi: 10.1038/sj.bjp.0706940. Epub 2006 Nov 27. Br J Pharmacol. 2007. PMID: 17128289 Free PMC article.
-
Cation and voltage dependence of lidocaine inhibition of the hyperpolarization-activated cyclic nucleotide-gated HCN1 channel.Sci Rep. 2017 Apr 28;7(1):1281. doi: 10.1038/s41598-017-01253-x. Sci Rep. 2017. PMID: 28455536 Free PMC article.
-
HCN channels and heart rate.Molecules. 2012 Apr 5;17(4):4225-35. doi: 10.3390/molecules17044225. Molecules. 2012. PMID: 22481543 Free PMC article. Review.
-
Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.J Physiol. 2006 Apr 15;572(Pt 2):335-46. doi: 10.1113/jphysiol.2005.100776. Epub 2006 Feb 16. J Physiol. 2006. PMID: 16484306 Free PMC article.
-
HCN2 channels: a permanent open state and conductance changes.J Membr Biol. 2015 Feb;248(1):67-81. doi: 10.1007/s00232-014-9742-0. Epub 2014 Nov 13. J Membr Biol. 2015. PMID: 25391723
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
